Grossmann, NC, Soria, F, Juvet, T, Potretzke, AM, Djaladat, H, Ghoreifi, A, Kikuchi, E, Mari, A, Khene, ZE, Fujita, K, Raman, JD, Breda, A, Fontana, M, Sfakianos, JP, Pfail, JL, Laukhtina, E, Rajwa, P, Pallauf, M, Poyet, C, Cacciamani, GE, van Doeveren, T, Boormans, JL, Antonelli, A, Jamil, M, Abdollah, F, Ploussard, G, Heidenreich, A, Storz, E, Daneshmand, S, Boorjian, SA, Roupret, M, Rink, M, Shariat, SF, Pradere, B. Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis. Cancers. 2023; 15(5)DOI:10.3390/cancers15051409. PMID:36900201. IF:4.500(Q1/3D).

Tarifa, C, Jimenez-Sabado, V, Franco, R, Montiel, J, Guerra, J, Ciruela, F, Hove-Madsen, L. Expression and Impact of Adenosine A(3) Receptors on Calcium Homeostasis in Human Right Atrium. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(5)DOI:10.3390/ijms24054404. PMID:36901835. IF:4.900(Q1/3D).

Moral S., Abulí M., Méndez I., González-Gómez A., García-Quintana A., Menduiña I., Payá R., Esteban E., Sánchez P.L., Díaz E., de la Morena G., Calvo-Iglesias F., Gallego P., Ballesteros E., Brugada R., Evangelista A.. Invasive management of significant tricuspid regurgitation in clinical practice. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2023; 375DOI:10.1016/j.ijcard.2023.01.005. PMID:36642332. IF:3.200(Q2/3D).

Panagides, V, Cheema, AN, Urena, M, Nombela-Franco, L, Veiga-Fernandez, G, Vilalta, V, Regueiro, A, Del Val, D, Asmarats, L, del Trigo, M, Serra, V, Munoz-Garcia, A, Rezaei, E, Himbert, D, Tirado-Conte, G, Hernandez, JMD, Fernandez-Nofrerias, E, Cepas-Guillen, PL, Alfonso, F, Gutierrez-Alonso, L, Dominguez, JFO, Belanech, Y, Paradis, JM, Mesnier, J, Rodes-Cabau, J. Optimal Degree of Balloon-Expandable Transcatheter Valve Oversizing in Patients With Borderline Aortic Annulus Measurements: Insights From a Multicenter Real-World Experience. Circulation-Cardiovascular Interventions. 2023; 16(3)DOI:10.1161/CIRCINTERVENTIONS.122.012554. PMID:36943930. IF:6.100(Q1/2D).

Bonfrate, L, Di Ciaula, A, Khalil, M, Farella, I, Chirico, R, Vilahur, G, Portincasa, P. Gender-dependent impact of COVID-19 lockdown on metabolic and psychological aspects. Internal and Emergency Medicine. 2023; 18(2)DOI:10.1007/s11739-022-03173-9. PMID:36703077. IF:3.200(Q1/2D).

Cordero, A, Munoz-Garcia, N, Padro, T, Vilahur, G, Bertomeu-Gonzalez, V, Escribano, D, Flores, E, Zuazola, P, Badimon, L. HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(6)DOI:10.3390/ijms24065391. PMID:36982465. IF:4.900(Q1/3D).

Sprankel L., Vizarraga D., Martín J., Manger S., Meier-Credo J., Marcos M., Julve J., Rotllan N., Scheffer M.P., Escolà-Gil J.C., Langer J.D., Piñol J., Fita I., Frangakis A.S.. Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas. NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2023; 30(3)DOI:10.1038/s41594-023-00922-y. PMID:36782049. IF:12.500(Q1/1D).

Alcubierre, N, Granado-Casas, M, Bogdanov, P, Hernandez, C, Ramos, H, Castelblanco, E, Real, J, Rubinat-Arnaldo, E, Traveset, A, Hernandez, M, Jurjo, C, Vioque, J, Navarrete-Munoz, EM, Simo, R, Mauricio, D. Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies. Nutrients. 2023; 15(5)DOI:10.3390/nu15051169. PMID:36904168. IF:4.800(Q1/2D).

Rodriguez-Calvo, R, Granado-Casas, M, de Oca, APM, Julian, MT, Domingo, M, Codina, P, Santiago-Vacas, E, Cediel, G, Julve, J, Rossell, J, Masana, L, Mauricio, D, Lupon, J, Bayes-Genis, A, Alonso, N. Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus. Antioxidants. 2023; 12(3)DOI:10.3390/antiox12030645. PMID:36978893. IF:6.000(Q1/2D).

Julve, J, Genua, I, Quifer-Rada, P, Yanes, O, Barranco-Altirriba, M, Hernandez, M, Junza, A, Capellades, J, Granado-Casas, M, Alonso, N, Castelblanco, E, Mauricio, D. Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2023; 197DOI:10.1016/j.diabres.2023.110578. PMID:36804334. IF:6.100(Q1/2D).

Díaz-Torné C., Pou M.A., Rodríguez-Díez B., Pujol-Ribera E.. Living with gout. Experiences, impact and challenges of the disease. Qualitative study through focus groups. Reumatologia Clinica. 2023; 19(3)DOI:10.1016/j.reuma.2022.03.009. PMID:36058814. IF:(Q/D).

Alvarez-Gutiérrez FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, González-Barcala FJ, Carretero-Gracia JÁ, Castilla-Martínez M, Cisneros C, Diaz-Pérez D, Domingo-Ribas C, Martínez-Moragon E, Muñoz X, Padilla-Galo A, Perpiña-Tordera M, Soto-Campos G. What's New in the 2022 Consensus for Severe Asthma in Adults.. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(3)DOI:10.1016/j.arbres.2022.09.012. PMID:36243640. IF:8.700(Q1/1D).

Waters, L, Assoumou, L, Gonzalez-Cordon, A, Rusconi, S, Domingo, P, Gompels, M, de Wit, S, Raffi, F, Stephan, C, Masia, M, Rockstroh, J, Katlama, C, Behrens, GMN, Moyle, G, Johnson, M, Fox, J, Stellbrink, HJ, Guaraldi, G, Florence, E, Esser, S, Gatell, JM, Pozniak, A, Martinez, E. Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial. CLINICAL INFECTIOUS DISEASES. 2023; 76(5)DOI:10.1093/cid/ciac827. PMID:36259527. IF:8.200(Q1/1D).

Nunez, Y, Garcia-Leon, A, Falgas, A, Serna, N, Sanchez-Garcia, L, Garrido, A, Sierra, J, Gallardo, A, Unzueta, U, Vazquez, E, Villaverde, A, Mangues, R, Casanova, I. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics. 2023; 15(3)DOI:10.3390/pharmaceutics15030727. PMID:36986589. IF:4.900(Q1/2D).

Berengua, C, Martino, R. Quantitative PCR for the Diagnosis of HCMV Pneumonia in HSCT Recipients and Other Immunocompromised Hosts. Hemato. 2023; 4(1)DOI:10.3390/hemato4010008. PMID:. IF:(Q/D).

Pedro-Botet J, Barrios V, Sánchez-Margalet V, Tamargo J, Arrieta F, Gámez JM, Gimeno-Orna JA, Escobar C, Gómez-Doblas JJ, Pérez A. Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society].. Endocrinologia Diabetes y Nutricion. 2023; 70(Suppl.1)DOI:10.1016/j.endien.2022.11.009. PMID:36402735. IF:1.800(Q3/8D).

Sanmarti, R, Corominas, H. Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review. Journal of Clinical Medicine. 2023; 12(5)DOI:10.3390/jcm12051734. PMID:36902522. IF:3.000(Q1/2D).

Laccourreye, O, Mirghani, H, Guiquerro, S, Quer, M, Giraud, P. Perception of survival/laryngeal preservation trade-off in advanced T-stage laryngeal cancer. European Annals of Otorhinolaryngology-Head and Neck Diseases. 2023; 140(2)DOI:10.1016/j.anorl.2022.12.008. PMID:36642664. IF:1.900(Q2/3D).

Bermudez-Tamayo, C, Hernandez, MN, Alguacil, J, Cantarero, D, Portino, MC, Casino, G, Calvente, MG, Hernan, M, Garcia, LP, Cantero, MTR, Segura, A, Amez, JG, Juarez, L, Miranda, JJ, March, JC, Marcos-Marcos, J, Mar, J, Peiro, R, Alvarez-Dardet, C. GACETA SANITARIA in 2022. Maximum historical impact factor and suitability for continuous publication. Gaceta Sanitaria. 2023; 37DOI:10.1016/j.gaceta.2023.102295. PMID:36871443. IF:1.500(Q3/7D).

Subiela J.D., Rodríguez Faba Ó., Aumatell J., Gonzalez-Padilla D.A., Rosales Bordes A., Huguet J., Krajewski W., Algaba F., López Curtis D., Brasero Burgos J., Sánchez González Á., Jiménez Cidre M.Á., Burgos Revilla F.J., Breda A., Palou J.. Long-term Recurrence and Progression Patterns in a Contemporary Series of Patients with Carcinoma In Situ of the Bladder With or Without Associated Ta/T1 Disease Treated with Bacillus Calmette-Guérin: Implications for Risk-adapted Follow-up. European Urology Focus. 2023; 9(2)DOI:10.1016/j.euf.2022.09.007. PMID:36163105. IF:4.900(Q1/2D).